EP
Epitomee Medical Ltd. (EPIT)
TASE
275.80
-5.50 (-1.96%)
Closed
Aug 25, 2026
Day's Range
270.10283.00
52 wk Range
270.101,049.00
Financial Statements - EPIT - Epitomee Medical Ltd.
Revenue
213.00K
Net Income
-8.61M▼ 488.3%Net Margin -4043.2%
EBITDA
-6.73M▲ 13.6%
Free Cash Flow
-9.49M▲ 26.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 213K | 0 | 10M | 0 | 0 | 0 |
| Cost of Goods | 867K | 0 | - | - | - | - |
| Gross Profit | -654K | 0 | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -9.53M | -8.97M | 416K | -11.06M | -8.77M | -3.84M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -8.61M | -1.46M | -5.68M | -15.39M | -11.51M | -3.16M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -8.61M | -1.46M | -5.68M | -15.39M | -11.51M | -3.16M |
| EPS Basic | - | -0.049 | -0.192 | -0.522 | -6.55 | -0.107514 |
| EPS Diluted | - | -0.049 | -0.192 | -0.522 | -6.55 | -0.107514 |
| Basic Shares Outstanding | - | 29.77M | 29.66M | 29.45M | 465.47K | 7.79M |
| Diluted Shares Outstanding | - | 29.77M | 29.66M | 29.45M | 465.47K | 7.79M |
| Ebit | -7.76M | -1.27M | -5.62M | -15.39M | -8.80M | -3.10M |
| Ebitda | -6.73M | -7.80M | 2.19M | -15.03M | -8.57M | -2.87M |
| Net Income Continuous Operations | -8.61M | -1.46M | -5.68M | -15.39M | -11.51M | -3.16M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
